Markets

Nexus Infrastructure Reports £70m Revenue, CEO to Step Down
UK infrastructure firm posts £70m in revenue as it announces an upcoming chief executive departure.

South Korea announces plans to reduce reliance on Middle East crude oil imports to 50% by 2035
Finance Review Daily is tracking this developing story; no further verified information could be confirmed at this time.

Aurrigo reports 19% revenue growth in first half of 2026
Finance Review Daily is tracking this developing story; no further verified information could be confirmed at this time.

DAX Gains as Iran-U.S. Talks Ease Oil Price Concerns
Germany's benchmark index opened higher Thursday as falling Brent crude and record Nasdaq gains offset political uncertainty at home.

Veradermics’ VDPHL01 Targets $135–$182 Valuation in Hair-Loss Pipeline
Veradermics’ oral minoxidil tablet aims to address a $1.5B+ U.S. market with strong physician and patient adoption expectations.

Judges Scientific CFO Brad Ormsby to leave in September 2027
Chief Financial Officer Brad Ormsby will step down on Sept 23, 2027 after a 12‑month notice, ending an 11‑year tenure at the scientific‑instrument group.

Candel Therapeutics Highlights Prostate Cancer Trial Progress at Cantor Conference
Candel Therapeutics outlined a Phase III trial showing a 30% improvement in disease-free survival for intermediate- to high-risk prostate cancer patients, with a 80% pathological response rate in two-year follow-ups.

Lexicon Pharmaceuticals CEO Highlights Focus on Obesity and Cardiomyopathy Programs
Lexicon Pharmaceuticals reported share declines amid strategic emphasis on obesity and heart disease programs, including a $45M upfront deal with Novo Nordisk for its ACSL5 inhibitor.

Braveheart Bio Outlines Dual HCM Pipeline at Cantor Conference
CEO Travis Murdock highlights Phase II results for BHB-1893 in obstructive and non-obstructive hypertrophic cardiomyopathy, with Phase III trials and regulatory timelines in focus.

UK FCA Weighs Fund Exemptions for Tokenized Gold
The Financial Conduct Authority is exploring a bespoke regulatory regime for tokenized gold products alongside the Bank of England and HM Treasury, aiming to expand tokenization in wholesale markets.

Trinity Industries Raises Quarterly Dividend to 31 Cents
Dallas-based rail equipment maker marks 250th consecutive dividend payment, raising the quarterly payout to $0.31 per share.

Aclaris Therapeutics Details Pipeline, Cash Runway at Cantor Fitzgerald Conference
The company says cash on hand funds programs through 2028. Top-line data for its ITK inhibitor in lichen planus is due in the second half of 2027.

Roche Nominates Former Takeda Chief Weber for Board Election
Pharmaceutical giant Roche has put forward Christophe Weber, former CEO of Takeda Pharmaceuticals, for election to its board of directors at the upcoming spring general assembly.

Solana Begins Testing Alpenglow Upgrade to Cut Finality to 150 Milliseconds
Solana's Alpenglow upgrade has moved to its public testnet, replacing TowerBFT consensus with Votor to reduce transaction finality from ~13 seconds to 0.15 seconds.

Royal Caribbean to acquire 50% stake in Sandals Resorts for $3B
Royal Caribbean announced plans to purchase a half‑interest in Sandals Resorts for $3 billion.

Malicious iOS App FomoPeek Tied to Nearly $580K Crypto Theft
SlowMist links a compromised App Store app with multiple kernel exploits to nearly $580,000 in stolen crypto across several blockchains.

China Reviews Broadcom Switch Use in State Data Centres
A survey found Broadcom switches may account for up to 90% of equipment at some state-owned firms, raising the prospect of Beijing pushing domestic alternatives.

Bitcoin Eyes First Three-Month Winning Streak Since 2012
Bitcoin's 10.9% September gain puts it on track for its first July–September winning streak since 2012, a pattern last followed by a 2,000% rally — though the setup faces an important caveat.

Ionis and Roche announce positive Phase 3 results for kidney drug
Ionis and Roche said their Phase 3 trial for a kidney treatment yielded positive data.

Parallel49 Equity-affiliated holders launch $PMTS secondary offering
CPI Card Group stockholders linked to Parallel49 Equity are selling up to 2.34 million shares in an underwritten secondary offering; the company receives no proceeds.

Asian equities rise driven by tech and AI demand while oil prices soften on Middle East supply reports
Asian stock markets advanced as technology and artificial‑intelligence demand boosted equities, while oil prices fell following reports on Middle East supply.

SMI leicht vorab höher, UBS-Kapitalvorschriften und Ölpreis im Fokus
Schweizer Aktienmärkte zeigen leichte Gewinne vor dem Handel, während die US-Börsen uneinheitlich schließen und Ölpreise weiter sinken.

BlackRock Sees AI Driving Structural Demand for Digital Assets
The asset manager's latest research argues that agentic AI and machine-to-machine payments make blockchains and stablecoins core infrastructure for an autonomous digital economy.

Immunocore Reports $431M Revenue, $880M Cash as Clinical Trials Advance
Immunocore’s KIMMTRAK leads growth in oncology pipeline, with trials expanding into cutaneous and adjuvant melanoma, while cash reserves support strategic flexibility.

Immuneering Pancreatic Cancer Data Draws Cantor Healthcare Conference Attention
Shares of Immuneering (IMRX) gained focus as the company presented Phase II results for its MEK inhibitor atebimetinib showing a 104% improvement in median overall survival versus historical benchmark.

